ORIC Pharmaceuticals Statistics

Total Valuation

ORIC has a market cap or net worth of $689.06 million. The enterprise value is $372.28 million.

Market Cap	689.06M
Enterprise Value	372.28M

Important Dates

The next estimated earnings date is Thursday, August 8, 2024, after market close.

Earnings Date	Aug 8, 2024
Ex-Dividend Date	n/a

Share Statistics

ORIC has 67.42 million shares outstanding. The number of shares has increased by 49.37% in one year.

Shares Outstanding	67.42M
Shares Change (YoY)	+49.37%
Shares Change (QoQ)	+17.07%
Owned by Insiders (%)	9.55%
Owned by Institutions (%)	96.10%
Float	36.18M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.10
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 21.31, with zero debt.

Current Ratio	21.31
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -38.10% and return on invested capital (ROIC) is -34.72%.

Return on Equity (ROE)	-38.10%
Return on Assets (ROA)	-34.80%
Return on Capital (ROIC)	-34.72%
Revenue Per Employee	n/a
Profits Per Employee	-$1.02M
Employee Count	100
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +34.47% in the last 52 weeks. The beta is 1.13, so ORIC's price volatility has been higher than the market average.

Beta (5Y)	1.13
52-Week Price Change	+34.47%
50-Day Moving Average	8.61
200-Day Moving Average	9.34
Relative Strength Index (RSI)	65.83
Average Volume (20 Days)	850,283

Short Selling Information

The latest short interest is 11.70 million, so 17.36% of the outstanding shares have been sold short.

Short Interest	11.70M
Short Previous Month	11.21M
Short % of Shares Out	17.36%
Short % of Float	32.34%
Short Ratio (days to cover)	19.32

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-114.09M
Pretax Income	-101.76M
Net Income	-101.76M
EBITDA	-100.72M
EBIT	-101.76M
Earnings Per Share (EPS)	-$1.81

Full Income Statement

Balance Sheet

The company has $316.78 million in cash and no debt, giving a net cash position of $316.78 million or $4.70 per share.

Cash & Cash Equivalents	316.78M
Total Debt	n/a
Net Cash	316.78M
Net Cash Per Share	$4.70
Equity (Book Value)	328.65M
Book Value Per Share	4.87
Working Capital	308.87M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$95.25 million and capital expenditures -$757,000, giving a free cash flow of -$96.00 million.

Operating Cash Flow	-95.25M
Capital Expenditures	-757,000
Free Cash Flow	-96.00M
FCF Per Share	-$1.43

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ORIC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-49.37%
Shareholder Yield	-49.37%
Earnings Yield	-14.77%
FCF Yield	-13.93%

Analyst Forecast

The average price target for ORIC is $20.29, which is 98.53% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$20.29
Price Target Difference	98.53%
Analyst Consensus	Strong Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2